Context Therapeutics® & Wisconsin Oncology Network Announce 1st Patient PhTrial
27 Oct 2021 //
GLOBENEWSWIRE
Context & Tyligand Bioscience Reach ONA-XR Manufacturing Optimization Milestone
25 Aug 2021 //
GLOBENEWSWIRE
Context, Jefferson to Evaluate Apristor Combination for adv. Endometrial Cancer
19 Sep 2019 //
BUSINESSWIRE
Context & World-Renowned Cancer Center Announce a Ph2 Trial for Apristor®
02 May 2019 //
BUSINESSWIRE
Arno Therapeutics Is Shuttering Its Doors
22 Dec 2017 //
BIOSPACE